Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MEMANTINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | MEMANTINE |
| Key Genes/Proteins | AKT, AMPK, AMYLOID, APP, BDNF, CREB |
| Related Diseases | ACETYLCHOLINE, ALZHEIMER, ALZHEIMER'S DISEASE, ALZHEIMERS_DISEASE, CHOLESTEROL |
Knowledge base pages for this entity
graph TD
MEMANTINE["MEMANTINE"]
MEMANTINE -->|"inhibits"| NMDA_RECEPTOR["NMDA RECEPTOR"]
MEMANTINE -->|"treats"| Dementia["Dementia"]
MEMANTINE -->|"treats"| Alzheimer_S_Disease["Alzheimer'S Disease"]
MEMANTINE -->|"treats"| Moderate_To_Severe_Dementia["Moderate To Severe Dementia"]
MEMANTINE -->|"treats"| Alzheimer_s_Disease["Alzheimer's Disease"]
MEMANTINE -->|"promotes"| Functional_Stabilization["Functional Stabilization"]
MEMANTINE -->|"activates"| NRF2["NRF2"]
MEMANTINE -->|"activates"| NMDA["NMDA"]
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"target for"| MEMANTINE
DEMENTIA["DEMENTIA"] -->|"inhibits"| MEMANTINE
CREB["CREB"] -->|"activates"| MEMANTINE
EXCITOTOXICITY["EXCITOTOXICITY"] -->|"activates"| MEMANTINE
DONEPEZIL["DONEPEZIL"] -->|"activates"| MEMANTINE
APP["APP"] -->|"produces"| MEMANTINE| Target | Relation | Type | Str |
|---|---|---|---|
| ad_clinical_trial_failures:memantine | data_in | dataset_row | 0.00 |
| ad_clinical_trial_failures:memantine | data_in | dataset_row | 0.00 |
| Dementia | treats | disease | 0.90 |
| Moderate To Severe Dementia | treats | disease | 0.90 |
| Alzheimer'S Disease | treats | disease | 0.90 |
| Alzheimer's Disease | treats | disease | 0.85 |
| Functional Stabilization | promotes | phenotype | 0.85 |
| Nrf2 | activates | pathway | 0.80 |
| Nrf2 Pathway | activates | pathway | 0.80 |
| NMDA receptor | inhibits | receptor | 0.80 |
| glutamate signaling | modulates | pathway | 0.80 |
| NRF2 | activates | protein | 0.80 |
| CREB/RCAN1 | activates | pathway | 0.80 |
| Alzheimer's Disease | treats | disease | 0.75 |
| Oxidative Stress | associated_with | process | 0.75 |
| NMDA | inhibits | entity | 0.70 |
| unfolded protein response | modulates | pathway | 0.70 |
| NMDA | activates | entity | 0.70 |
| Alzheimer's disease | treats | disease | 0.70 |
| NEURONS | protects_against | cell_type | 0.65 |
| NEURON | protects_against | cell_type | 0.65 |
| TAU | transports | gene | 0.65 |
| NEURODEGENERATION | exacerbates | disease | 0.65 |
| NEURODEGENERATION | activates | disease | 0.65 |
| TAU | phosphorylates | gene | 0.65 |
| NMDAR | treats | gene | 0.65 |
| NMDAR | regulates | gene | 0.65 |
| NMDAR | inhibits | gene | 0.65 |
| MICROGLIA | treats | cell_type | 0.65 |
| NEURODEGENERATION | regulates | phenotype | 0.65 |
| AKT | inhibits | gene | 0.65 |
| AKT | regulates | gene | 0.65 |
| AKT | treats | gene | 0.65 |
| INFLAMMATION | activates | phenotype | 0.65 |
| NEURODEGENERATION | inhibits | phenotype | 0.65 |
| ALZHEIMERS_DISEASE | treats | disease | 0.64 |
| depression | treats | disease | 0.60 |
| neuroinflammation | treats | disease | 0.60 |
| NMDA | targets | gene | 0.60 |
| NMDA receptor | treats | receptor | 0.60 |
| CREB | targets | gene | 0.60 |
| APP | targets | gene | 0.60 |
| NMDAR | targets | gene | 0.60 |
| APP | inhibits | gene | 0.60 |
| frontotemporal dementia | treats | disease | 0.60 |
| Parkinson's disease | treats | disease | 0.60 |
| APP | associated_with | gene | 0.60 |
| RCAN1 | targets | gene | 0.60 |
| NMDA receptor | secreted_by | receptor | 0.60 |
| NMDA receptor | activates | receptor | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ad_clinical_trial_failures:memantine | data_in | dataset_row | 0.00 |
| ad_clinical_trial_failures:memantine | data_in | dataset_row | 0.00 |
| ALZHEIMER'S DISEASE | treats | disease | 0.65 |
| ALZHEIMER | treats | disease | 0.65 |
| RIBOSOME | produces | organelle | 0.65 |
| GALANTAMINE | activates | drug | 0.65 |
| DONEPEZIL | associated_with | drug | 0.65 |
| EMPAGLIFLOZIN | treats | drug | 0.65 |
| NEURON | treats | cell_type | 0.65 |
| ALZHEIMER | causes | disease | 0.65 |
| ALZHEIMER'S DISEASE | regulates | disease | 0.65 |
| AKT | phosphorylates | gene | 0.65 |
| CHOLINERGIC | promotes | cell_type | 0.65 |
| APP | transports | gene | 0.65 |
| ACETYLCHOLINE | associated_with | phenotype | 0.50 |
| DOPAMINERGIC NEURONS | associated_with | cell_type | 0.50 |
| INFLAMMATION | associated_with | phenotype | 0.50 |
| CHOLESTEROL | associated_with | phenotype | 0.50 |
| NEURODEGENERATION | associated_with | phenotype | 0.50 |
| PARKINSON'S DISEASE | associated_with | disease | 0.50 |
| NEUROINFLAMMATION | associated_with | phenotype | 0.45 |
| COGNITIVE DECLINE | associated_with | phenotype | 0.45 |
| TIDEGLUSIB | associated_with | drug | 0.45 |
| NRF2 PATHWAY | associated_with | pathway | 0.45 |
| PRAMIPEXOLE | associated_with | drug | 0.45 |
| DEMENTIA | associated_with | disease | 0.45 |
| EXCITOTOXICITY | associated_with | phenotype | 0.45 |
| RIVASTIGMINE | associated_with | drug | 0.45 |
| GALANTAMINE | associated_with | drug | 0.45 |
| TAU PHOSPHORYLATION | associated_with | phenotype | 0.45 |
| CREB | associated_with | gene | 0.45 |
| MELATONIN | associated_with | drug | 0.45 |
| ALZHEIMER | associated_with | disease | 0.45 |
| GLUTAMATE | associated_with | phenotype | 0.45 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.45 |
| AKT | associated_with | gene | 0.45 |
| GLUTAMATE EXCITOTOXICITY | associated_with | phenotype | 0.45 |
| EMPAGLIFLOZIN | associated_with | drug | 0.45 |
| BARICITINIB | associated_with | drug | 0.45 |
| DEMENTIA | inhibits | disease | 0.35 |
| CREB | activates | gene | 0.35 |
| APP | produces | gene | 0.35 |
| APP | inhibits | gene | 0.35 |
| APP | therapeutic_target | gene | 0.35 |
| ALZHEIMER'S DISEASE | therapeutic_target | disease | 0.35 |
| AKT | activates | gene | 0.35 |
| ALZHEIMER'S DISEASE | activates | disease | 0.35 |
| EXCITOTOXICITY | activates | process | 0.35 |
| DONEPEZIL | activates | drug | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MEMANTINE in their description or question text
No additional research found